Legal & General Group
FENC icon

Legal & General Group’s Fennec Pharmaceuticals FENC Stock Holding History

Legal & General Group’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52.1K Buy
8,639
+511
+6% +$3.94K ﹤0.01% 2676
2025
Q4 		$62.8K Hold
8,128
– – ﹤0.01% 2687
2025
Q3 		$75.9K Hold
8,128
– – ﹤0.01% 2663
2025
Q2 		$67.4K Buy
8,128
+5,677
+232% +$38.8K ﹤0.01% 2677
2025
Q1 		$15K Hold
2,451
– – ﹤0.01% 3049
2024
Q4 		$15.5K Hold
2,451
– – ﹤0.01% 3117
2024
Q3 		$12.3K Hold
2,451
– – ﹤0.01% 3234
2024
Q2 		$15.1K Buy
2,451
+748
+44% +$6.21K ﹤0.01% 3141
2024
Q1 		$18.9K Hold
1,703
– – ﹤0.01% 2987
2023
Q4 		$19.1K Buy
1,703
+209
+14% +$1.73K ﹤0.01% 3047
2023
Q3 		$11.2K Sell
1,494
-444
-23% -$3.61K ﹤0.01% 3245
2023
Q2 		$17.1K Buy
+1,938
New +$16.1K ﹤0.01% 3178
2021
Q2 		– Sell
-2,473
Closed -$15K – 3546
2021
Q1 		$15K Sell
2,473
-243
-9% -$1.83K ﹤0.01% 3243
2020
Q4 		$20K Hold
2,716
– – ﹤0.01% 3087
2020
Q3 		$16K Sell
2,716
-841
-24% -$5.93K ﹤0.01% 3042
2020
Q2 		$30K Buy
+3,557
New +$26.5K ﹤0.01% 2891
2019
Q3 		– Sell
-1,681
Closed -$7K – 3376
2019
Q2 		$7K Hold
1,681
– – ﹤0.01% 3416
2019
Q1 		$8K Hold
1,681
– – ﹤0.01% 3275
2018
Q4 		$11K Hold
1,681
– – ﹤0.01% 3253
2018
Q3 		$14K Hold
1,681
– – ﹤0.01% 3279
2018
Q2 		$18K Buy
+1,681
New +$19.9K ﹤0.01% 3210

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM

Legal & General Group's FENC Position: Q1 2026 in Review

Legal & General Group increased its Fennec Pharmaceuticals (FENC) stake by 6.3% in Q1 2026, buying an estimated $3.94K and bringing the position to 8,639 shares worth $52.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2676.

Legal & General Group first reported a position in FENC in Q2 2018 and has held it in 21 quarters since. The position peaked at $75.9K in Q3 2025. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

  • Legal & General Group held 8,639 shares of Fennec Pharmaceuticals worth $52.1K as of Q1 2026.
  • Legal & General Group bought 511 Fennec Pharmaceuticals shares in Q1 2026, an estimated $3.94K.
  • Fennec Pharmaceuticals made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2676 holding.
  • Legal & General Group first reported a position in Fennec Pharmaceuticals in Q2 2018 and has held it in 21 quarters since.
  • Legal & General Group's Fennec Pharmaceuticals position peaked at $75.9K in Q3 2025.
  • 90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.